| For: | Lim JW, Dillon J, Miller M. Proteomic and genomic studies of non-alcoholic fatty liver disease - clues in the pathogenesis. World J Gastroenterol 2014; 20(26): 8325-8340 [PMID: 25024592 DOI: 10.3748/wjg.v20.i26.8325] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i26/8325.htm |
| Number | Citing Articles |
| 1 |
Renee Hernandez, Natasha S. Garcia-Rodriguez, Marco A. Arriaga, Ricardo Perez, Auwal A. Bala, Ana C. Leandro, Vince P. Diego, Marcio Almeida, Jason G. Parsons, Eron G. Manusov, Jacob A. Galan. The hepatocellular model of fatty liver disease: from current imaging diagnostics to innovative proteomics technologies. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1513598
|
| 2 |
Qing Ye, Bao-Xin Qian, Wei-Li Yin, Feng-Mei Wang, Tao Han, Pavel Strnad. Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls. PLOS ONE 2016; 11(9) doi: 10.1371/journal.pone.0163423
|
| 3 |
Heather L. Stevenson, Netanya S. Utay. Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era. Tropical Diseases, Travel Medicine and Vaccines 2016; 2(1) doi: 10.1186/s40794-016-0038-5
|
| 4 |
Manuel Suárez, Noemí Boqué, Josep Del Bas, Jordi Mayneris-Perxachs, Lluís Arola, Antoni Caimari. Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease. Nutrients 2017; 9(10) doi: 10.3390/nu9101052
|
| 5 |
Wenyu Cui, Ben Xu, Fuchun Chen, Weijun Shen, Fachun Wan, Anwei Cheng. Effects of grape peel phenolics on lipid accumulation in sodium palmitate-treated HepG2 cells. Journal of Functional Foods 2024; 112 doi: 10.1016/j.jff.2023.105923
|
| 6 |
Hong Xu, Gao-Feng Chen, Yu-Shui Ma, Hong-Wei Zhang, Yang Zhou, Guang-Hui Liu, Dong-Ya Chen, Jian Ping, Yi-Hui Liu, Xin Mou, Da Fu. Hepatic Proteomic Changes and Sirt1/AMPK Signaling Activation by Oxymatrine Treatment in Rats With Non-alcoholic Steatosis. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00216
|
| 7 |
Yuanye Jiang, Xiaoyu Zhuang, Jiaqi Zhang, Meng Li, Shengnan Du, Jiyun Tian, Yifu Yuan, Guang Ji, Cheng Hu. Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1171397
|
| 8 |
Hilmar K Lückhoff, Frederik C Kruger, Maritha J Kotze. Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries. World Journal of Hepatology 2015; 7(9): 1192-1208 doi: 10.4254/wjh.v7.i9.1192
|
| 9 |
Seyma Katrinli, Kamil Ozdil, Gizem Dinler-Doganay, Levent Doganay. Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment. 2018; doi: 10.5772/intechopen.71025
|
| 10 |
Xiaorui Yao, Fan Xia, Waijiao Tang, Chunxin Xiao, Miaoting Yang, Benjie Zhou. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats. Journal of Ethnopharmacology 2018; 212 doi: 10.1016/j.jep.2017.09.016
|
| 11 |
Eugenia Tsai, Tai-Ping Lee. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography. Clinics in Liver Disease 2018; 22(1) doi: 10.1016/j.cld.2017.08.004
|
| 12 |
Naohiko Nakamura, Etsuro Hatano, Kohta Iguchi, Motohiko Sato, Hiroaki Kawaguchi, Iwao Ohtsu, Takaki Sakurai, Nobuhiro Aizawa, Hiroko Iijima, Shuhei Nishiguchi, Takuya Tomono, Yukihiro Okuda, Seidai Wada, Satoru Seo, Kojiro Taura, Shinji Uemoto, Masaya Ikegawa. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5825-8
|
| 13 |
Ido Goldstein, Ville Paakinaho, Songjoon Baek, Myong-Hee Sung, Gordon L. Hager. Synergistic gene expression during the acute phase response is characterized by transcription factor assisted loading. Nature Communications 2017; 8(1) doi: 10.1038/s41467-017-02055-5
|
| 14 |
Mekonnen L. Dechassa, Volodymyr Tryndyak, Aline de Conti, Wenming Xiao, Frederick A. Beland, Igor P. Pogribny. Identification of chromatin‐accessible domains in non‐alcoholic steatohepatitis‐derived hepatocellular carcinoma. Molecular Carcinogenesis 2018; 57(8) doi: 10.1002/mc.22818
|
| 15 |
Fatmanur Er, Leyla Çimen, Ceren Suveren, Canan Yılmaz, Nurten Türközkan. Effects of Aerobic Exercise on Leukocyte-Mediated Liver Destruction in a Rat Model of Metabolic Syndrome. Gazi Medical Journal 2024; 35(4) doi: 10.12996/gmj.2024.4178
|
| 16 |
Chuze Xu, Sohaib Hasan Abdullah Ezzi, Xiaodi Zou, Yanzhao Dong, Ahmad Alhaskawi, Haiying Zhou, Vishnu Goutham Kota, Mohamed Hasan Abdulla Hasan Abdulla, Sahar Ahmed Abdalbary, Hui Lu. The role of TNF in metabolic disorders and liver diseases. Cytokine 2025; 190 doi: 10.1016/j.cyto.2025.156933
|
| 17 |
Gala Martín-Pozuelo, Rocío González-Barrio, Gonzalo Barberá, Amaya Albalat, Javier García-Alonso, William Mullen, Harald Mischak, María Periago. Tomato Juice Consumption Modifies the Urinary Peptide Profile in Sprague-Dawley Rats with Induced Hepatic Steatosis. International Journal of Molecular Sciences 2016; 17(11) doi: 10.3390/ijms17111789
|
| 18 |
Madushika Wimalarathne, Bailey L. Bowser, Albert B. Arul, Quiana C. Wilkerson-Vidal, Moses A. David, Emily C. Hunt, Helen Gibson, Renã A.S. Robinson, Sharifa T. Love-Rutledge. Hyperinsulinemic male LEW.1WR1 rats show early signs of impaired liver metabolism. Experimental and Molecular Pathology 2025; 141 doi: 10.1016/j.yexmp.2025.104955
|
| 19 |
Josep Maria del Bas, Benjamín Rodríguez, Francesc Puiggròs, Silvia Mariné, Miguel Angel Rodríguez, David Moriña, Lluís Armengol, Antoni Caimari, Lluís Arola. Hepatic accumulation of S-adenosylmethionine in hamsters with non-alcoholic fatty liver disease associated with metabolic syndrome under selenium and vitamin E deficiency. Clinical Science 2019; 133(3) doi: 10.1042/CS20171039
|
| 20 |
Andriana C. Kaliora, Aristea Gioxari, Ioanna Panagiota Kalafati, Anastasia Diolintzi, Alexandros Kokkinos, George V. Dedoussis. The Effectiveness of Mediterranean Diet in Nonalcoholic Fatty Liver Disease Clinical Course: An Intervention Study. Journal of Medicinal Food 2019; 22(7) doi: 10.1089/jmf.2018.0020
|
| 21 |
Julia Blomdahl, Mikael Åberg, Michael Fridén, Håkan Ahlström, Paul Hockings, Johannes Hulthe, Niclas Eriksson, Katja Gabrysch, Patrik Nasr, Ulf Risérus, Stergios Kechagias, Fredrik Rorsman, Mattias Ekstedt, Johan Vessby. Proteomic signatures for fibrosis in MASLD: a biopsy-proven dual-cohort study. Scandinavian Journal of Gastroenterology 2025; 60(6) doi: 10.1080/00365521.2025.2490996
|
| 22 |
Wenqing Mei, Yarong Hao, Huilin Xie, Yingdong Ni, Ruqian Zhao. Hepatic Inflammatory Response to Exogenous LPS Challenge is Exacerbated in Broilers with Fatty Liver Disease. Animals 2020; 10(3) doi: 10.3390/ani10030514
|
| 23 |
Sina Mohagheghi, Zohreh Khajehahmadi, Heidar Tavilani. Signaling in Simple Steatosis and Non-alcoholic Steatohepatitis Cirrhosis: TGF-β1, YAP/TAZ, and Hedgehog Pathway Activity. Avicenna Journal of Medical Biochemistry 2018; 6(2) doi: 10.15171/ajmb.2018.07
|
| 24 |
Man-Yi Sun, Li Zhang, Song-Li Shi, Jing-Na Lin, Graham R. Wallace. Associations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis. PLOS ONE 2016; 11(4) doi: 10.1371/journal.pone.0154337
|
| 25 |
Le Ying, Feng Yan, Yueling Zhao, Hugh Gao, Bryan RG Williams, Yiqun Hu, Xiaofang Li, Run Tian, Ping Xu, Yuefei Wang. (‐)‐Epigallocatechin‐3‐gallate and atorvastatin treatment down‐regulates liver fibrosis‐related genes in non‐alcoholic fatty liver disease. Clinical and Experimental Pharmacology and Physiology 2017; 44(12) doi: 10.1111/1440-1681.12844
|
| 26 |
Diego Almanza, Mehrnaz Gharaee-Kermani, Alisa Zhilin-Roth, Jose A. Rodriguez-Nieves, Cory Colaneri, Todd Riley, Jill A. Macoska. Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature. Digestive Diseases and Sciences 2019; 64(5) doi: 10.1007/s10620-018-5398-4
|
| 27 |
Natalia Nuño-Lámbarri, Varenka Barbero-Becerra, Misael Uribe, Norberto Chávez-Tapia. Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach. International Journal of Molecular Sciences 2016; 17(3) doi: 10.3390/ijms17030281
|
| 28 |
Peng Ma, Rongrong Huang, Yu Ou. A soy glycinin derived octapeptide protects against MCD diet induced non-alcoholic fatty liver disease in mice. Food Science and Human Wellness 2022; 11(6) doi: 10.1016/j.fshw.2022.06.012
|
| 29 |
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 2016; 65(8) doi: 10.1016/j.metabol.2016.05.003
|
| 30 |
Somaya Albhaisi, Arun J. Sanyal. Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date. Pharmaceutical Medicine 2019; 33(6) doi: 10.1007/s40290-019-00305-z
|
| 31 |
Fabrizio Ceciliani, Cristina Lecchi, Christiane Urh, Helga Sauerwein. Proteomics and metabolomics characterizing the pathophysiology of adaptive reactions to the metabolic challenges during the transition from late pregnancy to early lactation in dairy cows. Journal of Proteomics 2018; 178 doi: 10.1016/j.jprot.2017.10.010
|
| 32 |
Achuthan Sourianarayanane, Ju-Seog Lee, Honsoul Kim, Brett S Phinney. Correlation of Plasma and Liver Tissue Proteomics for Plasma Biomarkers in Metabolic Dysfunction-Associated Steatotic Liver Disease. Journal of Proteome Research 2026; 25(2) doi: 10.1021/acs.jproteome.5c00749
|
| 33 |
Wensheng Liu, Robert D. Baker, Tavleen Bhatia, Lixin Zhu, Susan S. Baker. Pathogenesis of nonalcoholic steatohepatitis. Cellular and Molecular Life Sciences 2016; 73(10) doi: 10.1007/s00018-016-2161-x
|
| 34 |
Nwe Ni Than, Philip N. Newsome. A concise review of non-alcoholic fatty liver disease. Atherosclerosis 2015; 239(1) doi: 10.1016/j.atherosclerosis.2015.01.001
|
| 35 |
Achuthan Sourianarayanane, Michelle R. Salemi, Brett S. Phinney, Arthur J. McCullough. Liver Tissue Proteins Improve the Accuracy of Plasma Proteins as Biomarkers in Diagnosing Metabolic Dysfunction‐Associated Steatohepatitis. PROTEOMICS – Clinical Applications 2024; 18(6) doi: 10.1002/prca.202300236
|